Vice President, Cardovascular and Metabolic Franchise @ Novartis
Executive Director, R and D, Cardiovascular and Metabolic Medicine Development Center @ GSK
Senior Director, R and D, Cardiovascular and Metabolic Medicine Development Center @ GSK
Shunichiro Okada's Education
University of Pennsylvania
Cardiology Fellowship
1989 - 1993
University of Pittsburgh School of Medicine
Residency in Internal Medicine; Post-Doctoral Fellowship in Basic Science
1985 - 1989
The University of Texas Southwestern Medical School
Doctor of Medicine - MD (Medicine)
1981 - 1985
The Johns Hopkins University
Bachelor of Arts (BA)
1977 - 1981
Shunichiro Okada's Skills
Japanese
GI
Stem Cell Research
Research and Development
Clinical Trials
Modeling and Simulation
Translational Medicine
Genotyping
Japanese market
Pad
Shunichiro Okada's Summary
Shunichiro Okada, based in Guilford, CT, US, is currently a Chief Medical Officer at Invea Therapeutics, bringing experience from previous roles at VisiCELL Medical, T-CiRA Group, InveniAI, LLC and Invea Therapeutics, Inc. and Takeda Pharmaceuticals. Shunichiro Okada holds a 1989 - 1993 Cardiology Fellowship @ University of Pennsylvania. With a robust skill set that includes Japanese, GI, Stem Cell Research, Research and Development, Clinical Trials and more, Shunichiro Okada contributes valuable insights to the industry. Shunichiro Okada has 7 emails and 1 mobile phone number on RocketReach.